Kodiak Sciences saw its shares surge over 162% after its experimental drugs Zenkuda and tabirafusp-ted met primary endpoints in the phase III DAYBREAK trial for wet age-related macular degeneration (AMD). Both drugs showed vision gains comparable to the current treatment aflibercept at one year, with Zenkuda achieving extended dosing intervals for over half of patients. Tabirafusp-ted also met a key secondary anatomical endpoint, and both drugs demonstrated safety consistent with aflibercept. Kodiak plans to submit a biologics license application for Zenkuda in Q4 2026, targeting approval for wet AMD, diabetic retinopathy, and macular edema.
Kodiak Sciences' recent drug trial success offers context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Sep 28, 2026 23:41 WIB: Among 100 priced US health-sector stocks, 53 rose and 47 fell. Notable movers include TXG at USD 88.75 with a 3.55% increase and a typical hold time of 93 days, ADMA at USD 9.71 up 3.52% with a 17-day hold, and REGN at USD 763.07 down 3.17% with a 106-day hold time.
BlockchainK2 Corp. announced Michael Forstl as its new CEO starting October 1, 2026, succeeding Sergei Stetsenko who will remain Executive Chairman. Forstl brings over 30 years of experience in institutional distribution and digital-asset investing, ...
REX Shares and Osprey Funds have submitted an updated filing with the SEC for a proposed SEI Staked ETF, which would allow investors to gain exposure to the SEI token combined with on-chain staking within a regulated fund structure. This filing is an...
Zcash (ZEC) experienced a sharp decline, falling 7.2% over 24 hours to $1,492 as of September 28. The price dropped from $1,523 within an hour, reflecting significant market movement. This decline coincided with $2.14 million in long position liquida...
Nvidia has introduced OpenShell, a new open-source software designed to securely run autonomous AI agents in isolated environments, aiming to prevent incidents like the recent hack of Hugging Face by rogue OpenAI agents. This software enforces strict...
Equity-income strategies, including traditional dividend ETFs and option-income ETFs, are struggling due to slowing growth, persistent inflation, and high valuations. While dividend ETFs like SCHD, VIG, VYM, and DVY provide real dividend income, thei...
